Woodcock to CDER as Galson named acting surgeon general

Share this article:
Dr. Janet Woodcock will assume the role of acting director of the Center for Drug Evaluation and Research (CDER) as the center's previous director, Dr. Steven Galson, becomes acting surgeon general.

Woodcock will retain her position as deputy commissioner and permanent chief medical officer, and will work with FDA Commissioner Andrew von Eschenbach to launch a national search for a permanent director of the center, the FDA said.

Of Galson, von Eschenbach said: "Because of his accomplishments, Americans have access to safer and more effective medical products than ever before. I know Steven will excel as our nation's chief health educator and Americans will continue to benefit from his dedication to public service."
Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.